Sarissa Capital Management as of Dec. 31, 2020
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 12 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 16.3 | $160M | 14M | 11.39 | |
| Alkermes SHS (ALKS) | 16.2 | $159M | 8.0M | 19.95 | |
| Biogen Idec (BIIB) | 16.1 | $157M | 643k | 244.86 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 15.6 | $153M | 928k | 165.05 | |
| Alexion Pharmaceuticals | 12.7 | $125M | 798k | 156.24 | |
| Innoviva (INVA) | 8.1 | $80M | 6.4M | 12.39 | |
| Mersana Therapeutics (MRSN) | 7.9 | $78M | 2.9M | 26.61 | |
| BioCryst Pharmaceuticals (BCRX) | 6.2 | $61M | 8.2M | 7.45 | |
| Sarissa Capital Acquisitn W Exp 10/23/202 | 0.5 | $5.0M | 3.3M | 1.50 | |
| Regulus Therapeutics Com New | 0.3 | $2.5M | 1.9M | 1.35 | |
| Mirati Therapeutics | 0.0 | $219k | 1.0k | 219.00 | |
| Intercept Pharmaceuticals In | 0.0 | $23k | 950.00 | 24.21 |
